• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二苯拉林(利戈宾)治疗变应性和血管运动性鼻炎患者。

Diphenylpyraline (Lergobine) in the treatment of patients suffering from allergic and vasomotor rhinitis.

作者信息

Puhakka H, Rantanen T, Virolainen E

出版信息

J Int Med Res. 1977;5(1):37-41. doi: 10.1177/030006057700500106.

DOI:10.1177/030006057700500106
PMID:14039
Abstract

In a double-blind study, diphenylpyraline (Lergobine) was given to 63 patients whose main symptoms were stuffiness of the nose, increased secretion of mucus, snuffling, sneezing and redness of the eyes. Fifty-seven patients were given placebo for identical symptoms. Diphenylpyraline was found to have a better effect on all the symptoms than placebo. The difference was statistically significant in respect of the discharge of mucus and redness of the eyes, and when the total symptoms were considered as a whole. In atopic patients the better effect of diphenylpyraline was highly significant.

摘要

在一项双盲研究中,给63名主要症状为鼻塞、黏液分泌增多、抽鼻涕、打喷嚏和眼睛发红的患者服用了二苯拉林(Lergobine)。给57名有相同症状的患者服用了安慰剂。结果发现,二苯拉林对所有症状的疗效均优于安慰剂。在黏液分泌和眼睛发红方面,以及将所有症状作为一个整体考虑时,差异具有统计学意义。在特应性患者中,二苯拉林的较好疗效非常显著。

相似文献

1
Diphenylpyraline (Lergobine) in the treatment of patients suffering from allergic and vasomotor rhinitis.二苯拉林(利戈宾)治疗变应性和血管运动性鼻炎患者。
J Int Med Res. 1977;5(1):37-41. doi: 10.1177/030006057700500106.
2
A double blind trial of terfenadine and placebo in hay fever using a substitution technique for non-responders.一项使用替代技术针对无反应者的特非那定与安慰剂治疗花粉热的双盲试验。
J Int Med Res. 1980;8(6):404-7. doi: 10.1177/030006058000800607.
3
[Clinical experience with an anti-rhinitis drug. Double-blind clinical comparative study with a modified drug].[一种抗鼻炎药物的临床经验。与改良药物的双盲临床对照研究]
Clin Ter. 1979 Mar 15;88(5):499-507.
4
Comparative clinical studies with ebastine: efficacy and tolerability.依巴斯汀的比较临床研究:疗效与耐受性
Drug Saf. 1999;21 Suppl 1:63-7; discussion 81-7. doi: 10.2165/00002018-199921001-00008.
5
Loratadine (SCH29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of seasonal allergic rhinitis.氯雷他定(SCH29851)每日一次40毫克与特非那定每日两次60毫克治疗季节性变应性鼻炎的对比研究。
J Int Med Res. 1987 Mar-Apr;15(2):63-70. doi: 10.1177/030006058701500201.
6
Clinical investigation of terfenadine, a non-sedating antihistamine.特非那定(一种非镇静性抗组胺药)的临床研究。
Ann Allergy. 1980 Feb;44(2):71-5.
7
Treatment of seasonal allergic rhinitis--a double blind, group comparative study of terfenadine and dexchlorpheniramine.季节性变应性鼻炎的治疗——特非那定与右氯苯那敏的双盲、组间对比研究
Rhinology. 1987 Mar;25(1):35-40.
8
Multicenter, double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis.
Ann Allergy. 1985 Jun;54(6):502-9.
9
Terfenadine--a non-sedating antihistamine.特非那定——一种非镇静性抗组胺药。
Med Lett Drugs Ther. 1985 Aug 2;27(693):65-6.
10
French multicentre double-blind study to evaluate the efficacy and safety of acrivastine as compared with terfenadine in seasonal allergic rhinitis.一项法国多中心双盲研究,旨在评估阿伐斯汀与特非那定相比在季节性变应性鼻炎中的疗效和安全性。
J Int Med Res. 1989;17 Suppl 2:47B-53B.

引用本文的文献

1
Effects of the histamine H₁ receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward.组胺 H₁ 受体拮抗剂和苯托品类似物二苯哌嗪对多巴胺摄取、运动和奖励的影响。
Eur J Pharmacol. 2012 May 15;683(1-3):161-5. doi: 10.1016/j.ejphar.2012.03.003. Epub 2012 Mar 15.